Alison LorenAdam CukerMikkael SekeresThe American Society of Hematology announced the election of three new members to its executive committee for terms starting after the 2025 ASH Annual Meeting on Dec. 6-9 in Orlando.
Armando E. Giuliano will receive the William L. McGuire Memorial Lecture Award during the 2025 San Antonio Breast Cancer Symposium, to be held Dec. 9-12 at the Henry B. Gonzalez Convention Center in San Antonio.
The Tampa General Hospital Cancer Institute has been accepted into the Association of American Cancer Institutes, a recognition of its commitment to excellence in cancer research, treatment, education, and community outreach and engagement.
CTMC, a joint venture between Resilience and MD Anderson Cancer Center, has entered into a collaborative partnership with Einstein Hospital Israelita in Sao Paulo, Brazil, aimed at accelerating the adoption of cell therapy in Brazil and all of Latin America.
The START Center for Cancer Research, the world’s largest community-based network specializing in early-phase oncology clinical trials, together with HM Hospitales, announced the launch of a pediatric onco-hematology clinical research unit at HM Montepríncipe University Hospital in Madrid.
Cornelia UlrichDiane M. SimeoneBarry P. SleckmanCornelia Ulrich was selected to serve as vice president/president-elect of the Association of American Cancer Institute’s board of directors. Ulrich is chief scientific officer and executive director of the Comprehensive Cancer Center at Huntsman Cancer Institute at the University of Utah.
Paul Boutros was named director of the NCI-designated Basic Laboratory Cancer Center at Sanford Burnham Prebys Medical Discovery Institute.
NCI has awarded a five-year, $11.2 million Cancer Health Disparities Specialized Program of Research Excellence in Endometrial Cancer grant to Victoria Bae-Jump and Hazel Nichols at the University of North Carolina Lineberger Comprehensive Cancer Center.
Ruth Rechis was named chief prevention officer the Cancer Prevention & Research Institute of Texas.
Researchers at Moffitt Cancer Center have been awarded a $22.4 million grant from the U.S. Department of War to lead studies and clinical trials for leptomeningeal disease, a devastating complication of breast and other cancers that spreads to the coverings of the brain and spinal cord.
